首页 正文

Evolving Role of GLP-1 Therapies in Liver Disease

{{output}}
Purpose of review: Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the leading cause of chronic liver disease. This risk paralleled the rise in obesity rates, making MASLD a consequence of the Metaboli... ...